Nielsen E Husted, Lindholm J, Bjerre P, Christiansen J Sandahl, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P
Department of Endocrinology, Aarhus University Hospital, Aalborg, Denmark.
Clin Endocrinol (Oxf). 2006 Mar;64(3):319-22. doi: 10.1111/j.1365-2265.2006.02463.x.
There is agreement in the literature that pituitary apoplexy is a rare disorder. As our experience differs from this view, we analysed the incidence in patients operated on for a nonfunctioning pituitary adenoma.
One hundred ninety-two consecutive patients with a suprasellar, clinically inactive adenoma operated on during the period 1985-1996 were retrospectively reviewed. A diagnosis of pituitary apoplexy was made from relevant neurological symptoms together with pertinent findings at operation.
Pituitary apoplexy occurred in 41 patients (21%), in 23 patients within 12 days prior to the operation. The male/female ratio was 1.9. Median follow-up time was 13.7 years (range 8.9-19.9). During this period, 12 patients had died, yielding a standard mortality ratio of 1.09 (95% CI 0.62-1.92), similar to that in the patients who had not sustained pituitary apoplexy. Postoperatively, 24% of the patients had normal pituitary function, 38% were panhypopituitary and partial pituitary insufficiency was present in 38%. Subnormal GH secretion was present in virtually all patients tested. Two patients died within 60 days of surgery and in two no or incomplete data were available, although they most likely were panhypopituitary.
Most of our findings add little to what is known about pituitary apoplexy. On one point, however, they are contrary to previously presented data. We found a much higher incidence of pituitary apoplexy despite rather rigorous criteria for the diagnosis. The outcome as regards survival and endocrine function was not different from that in patients with a nonfunctioning adenoma who did not suffer pituitary apoplexy.
文献中一致认为垂体卒中是一种罕见疾病。鉴于我们的经验与这一观点不同,我们分析了因无功能性垂体腺瘤接受手术治疗患者的垂体卒中发生率。
回顾性分析了1985年至1996年期间连续接受鞍上无功能性腺瘤手术的192例患者。根据相关神经症状及手术中的相关发现做出垂体卒中的诊断。
41例患者(21%)发生垂体卒中,其中23例在手术前12天内发生。男女比例为1.9。中位随访时间为13.7年(范围8.9 - 19.9年)。在此期间,12例患者死亡,标准化死亡率为1.09(95%可信区间0.62 - 1.92),与未发生垂体卒中的患者相似。术后,24%的患者垂体功能正常,38%为全垂体功能减退,38%存在部分垂体功能不全。几乎所有接受检测的患者生长激素分泌均低于正常水平。2例患者在术后60天内死亡,2例没有或仅有不完整的数据,尽管他们很可能是全垂体功能减退。
我们的大多数发现对垂体卒中已知内容的补充不多。然而,在一点上,它们与先前公布的数据相反。尽管诊断标准相当严格,但我们发现垂体卒中的发生率要高得多。在生存和内分泌功能方面的结果与未发生垂体卒中的无功能性腺瘤患者并无差异。